Hanson Kristopher 4
4 · MapLight Therapeutics, Inc. · Filed May 6, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) General Counsel Kristopher Hanson Sells Shares
What Happened
- Kristopher Hanson, General Counsel of MapLight Therapeutics (MPLT), sold a total of 13,917 shares in open-market transactions on May 4, 2026, generating aggregate proceeds of $388,177.
- Individual sales reported:
- 9,030 shares @ weighted avg $27.50 — $248,325 (F2; trades ranged $26.84–$27.835)
- 3,908 shares @ weighted avg $28.29 — $110,557 (F3; trades ranged $27.845–$28.73)
- 296 shares @ weighted avg $29.56 — $8,750 (F4; trades ranged $29.00–$29.9669)
- 683 shares @ weighted avg $30.08 — $20,545 (F5; trades ranged $30.00–$30.55)
- These were sales (code "S"), which are generally routine dispositions rather than purchases that might signal conviction.
Key Details
- Transaction date: May 4, 2026; Form 4 filed May 6, 2026 (filed within the standard two-business-day window).
- Total shares sold: 13,917; total proceeds: $388,177.
- Shares owned after transaction: not disclosed in the provided filing.
- Notable footnotes:
- F1: Transactions were made pursuant to a Rule 10b5-1 trading plan adopted December 29, 2025 (pre-established plan).
- F2–F5: Reported prices are weighted averages; each footnote gives the per-trade price ranges and the filer offers to supply the breakdown on request.
- Transaction type: S = Sale.
Context
- 10b5-1 plans are pre-set trading arrangements that allow insiders to sell according to an established schedule; trades under such plans are commonly considered routine and are designed to avoid allegations of trading on material nonpublic information.
- Sales do not necessarily indicate negative views of the company; purchases are typically more informative about insider sentiment.
Insider Transaction Report
Form 4
Hanson Kristopher
General Counsel
Transactions
- Sale
Voting Common Stock
[F1][F2]2026-05-04$27.50/sh−9,030$248,325→ 181,135 total - Sale
Voting Common Stock
[F1][F3]2026-05-04$28.29/sh−3,908$110,557→ 177,227 total - Sale
Voting Common Stock
[F1][F4]2026-05-04$29.56/sh−296$8,750→ 176,931 total - Sale
Voting Common Stock
[F1][F5]2026-05-04$30.08/sh−683$20,545→ 176,248 total
Footnotes (5)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $27.835 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.845 to $28.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.9669 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Kristopher L. Hanson|2026-05-06